Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
An Addendum to Sexual and Reproductive Health (SRH) Policy Guidelines and Service Standards
Vol. 7, No. 1 (2018) | ISSN 2166-7403 (online) DOI 10.5195/cajgh.2018.295 | http://cajgh.pitt.edu
Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z
No publication year indicated
Medical Journal of Zambia, Volume 36 Number 4 (2009)
Policy Brief, Updated in March 2017
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...ort is to provide forecasts of future demand for medicines used in the fields of HIV, viral hepatitis and STIs. This report jointly presents medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner.
more
Meeting report
Geneva, 16-18 November 2016
Decree of the Minister of Health of the Republic of Indonesia Number 1190 / MENKES / SK / X / 2004 on the Free Drug of Anti Tuberculosis (OAT) and Anti Retro Viral (ARV) Drugs for HIV / AIDS
- A Skills Building Program for Clinicians and Non-Clinicians. Adherence guidelines- slide deck- training course for health providers